Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas (Q27851640)

From Wikidata

Jump to navigation Jump to search

scientific article

Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas

Language	Label	Description	Also known as
English	Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas	scientific article	Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas

Statements

scholarly article

1 reference

PubMed publication ID

13 November 2016

Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas (English)

1 reference

PubMed publication ID

13 November 2016

Leandro Cerchietti

1

object named as

Leandro Cerchietti

0 references

3

object named as

Inga Vater

0 references

Christine Damm-Welk

2

object named as

Christine Damm-Welk

0 references

9

object named as

Reiner Siebert

0 references

author name string

Christine Damm-Welk

2

0 references

Wolfram Klapper

4

0 references

Lana Harder

5

0 references

Christiane Pott

6

0 references

Shao Ning Yang

7

0 references

Alfred Reiter

8

0 references

Ari Melnick

10

0 references

Willi Woessmann

11

0 references

language of work or name

0 references

publication date

8 April 2011

0 references

0 references

6

0 references

4

0 references

e18436

0 references

copyright license

Creative Commons Attribution 4.0 International

8 April 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3072987/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

20 March 2017

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

20 March 2017

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

20 March 2017

The anaplastic lymphoma kinase in the pathogenesis of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

29 September 2017

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

29 September 2017

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

29 September 2017

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

29 September 2017

Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

29 September 2017

Anaplastic lymphoma kinase proteins in growth control and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

29 September 2017

Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

29 September 2017

A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

29 September 2017

ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0018436

21 January 2018

ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0018436

21 January 2018

Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation.

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0018436

21 January 2018

Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0018436

21 January 2018

Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0018436

21 January 2018

Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0018436

21 January 2018

Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0018436

21 January 2018

Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0018436

21 January 2018

Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072987

27 November 2018

CD30( ) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/21494621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21494621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0018436

0 references

2011PLoSO...618436C

0 references

PMC publication ID

1 reference

PubMed publication ID

13 November 2016

PubMed publication ID

1 reference

PubMed publication ID

13 November 2016

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27851640&oldid=1869417673"